NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
09 mai 2024 09h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program. KidsX is a global leader in pediatric digital...
Finnish Hospital Orders Nexstim NBS System 5
08 mai 2024 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 8 May 2024 at 9 AM (EEST) Finnish Hospital Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
03 mai 2024 07h00 HE
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...
Pacific Clinics Announces 100 Job Openings in Bay Area
25 avr. 2024 16h42 HE
|
Pacific Clinics
Campbell, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Pacific Clinics, California’s leading provider of community-based mental health and substance use services, has more than 100 open job positions...
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
23 avr. 2024 08h15 HE
|
Silo Pharma, Inc.
Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”),...
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
17 avr. 2024 08h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, April 17, 2024 (GLOBE NEWSWIRE) -- An astonishing 44% of Americans feel they have lost time in their lives due to poor mental health. That number jumps to nearly 80% for those...
Enhancing Positive Emotions to Prevent Depression in Youth - A Free Webinar from the Brain & Behavior Research Foundation
02 avr. 2024 10h30 HE
|
Brain & Behavior Research Foundation
New York, April 02, 2024 (GLOBE NEWSWIRE) -- The CDC has reported alarming rates of depression among America’s youth, with 42% of high school students feeling so sad or hopeless almost every day for...
Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region
13 mars 2024 14h13 HE
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution...
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
29 févr. 2024 07h00 HE
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial of GH001 in postpartum...
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
30 janv. 2024 09h18 HE
|
Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions